In our study, we did not observe an elevation in BNP levels, likely because our patient population had structurally normal hearts and because the chemotherapy doses were lower than those used on patients with hematological neoplasms [10]. This evidence concerns the gene NPPB and hematopoietic and lymphoid system neoplasm.